| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |